While large shRNA genomic screens have suggested that PEAK1 is involved in cancer cell proliferation [33], our recent report is the first to directly link PEAK1 function with cancer progression and demonstrate that PEAK1 levels are amplified in over 80% of colon cancer patients (primary and metastatic lesions). Here, PEAK1 is linked to malignant colon neoplasm.